BUSULFAN+ SIKLOFOSFAMID PROTOKOLÜ

Kaynaklar:

1- Radich, J. P., T. Gooley, W. Bensinger, et al. 2003. "HLA-matched related hematopoietic cell transplantation for chronic-phase CML using a targeted busulfan and cyclophosphamide preparative regimen." Blood 102(1):31-35.

2-Andersson BS, Thall PF, Madden T et al. 2002 "Busulfan systemic exposure relative to regimen-related toxicity and acute graft-versus-host disease: defining a therapeutic window for i.v. BuCy2 in chronic myelogenous leukemia". Biol Blood Marrow Transplant ;8(9):477-85.

3-Kashyap A, Wingard J, Cagnoni P et al. 2002 "Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-day mortality". Biol Blood Marrow Transplant ;8(9):493-500.

4-Lui H, Zhai Z, Song Z et al. 2013. “Busulfan plus fludarabine as a myeloablative condiitoing regimen compared with buslfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and multicentre study”. J Hematol Oncol 6:1 Read abstract 12 Lee, J. H., Y. D. Joo, H. Kim, et al. 2013. "Randomized trial of myeloablative conditioning regimens: busulfan plus cyclophosphamide versus busulfan plus fludarabine." J Clin Oncol 31(6):701-70.

5-Ben-Barouch, S., O. Cohen, L. Vidal, et al. 2016. "Busulfan fludarabine vs busulfan cyclophosphamide as a preparative regimen before allogeneic hematopoietic cell transplantation: systematic review and meta-analysis." Bone Marrow Transplant 51(2):232-240.

6-Lei, X. R., H. L. Chen, F. X. Wang, et al. 2015. "Busulfan plus fludarabine compared with busulfan plus cyclophosphamide as a conditioning regimen prior to hematopoietic stem cell transplantation in patients with hematologic neoplasms: a meta-analysis." Int J Clin Exp Med 8(8):12064-12075.

7-Nagler, A., V. Rocha, M. Labopin, et al. 2013. "Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia working party of the European group for blood and marrow transplantation." J Clin Oncol 31(28):3549-3556.

8-Socie, G., R. A. Clift, D. Blaise, et al. 2001. "Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies." Blood 98(13):3569-3574.